ClinConnect ClinConnect Logo
Search / Trial NCT05901870

Russian National Health Telephone Survey (RNHTS)

Launched by I.M. SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY · Jun 9, 2023

Trial Information

Current as of May 14, 2025

Active, not recruiting

Keywords

Health Status Health Related Quality Of Life Health Related Behaviors Health Care Utilization Telephone Survey National Health Survey

ClinConnect Summary

The Russian National Health Telephone Survey (RNHTS) is a study aimed at understanding the health and well-being of adults in Russia. Researchers want to learn about how people feel about their health, their health-related habits, and how often they use healthcare services. To gather this information, they will conduct phone interviews with a variety of adult participants across the country.

To be eligible for this survey, individuals must be 18 years or older and able to give permission for their participation over the phone. Unfortunately, those who are very ill, have serious cognitive issues, or struggle with hearing or speaking may not be able to join. If you participate, you can expect a friendly phone call where you’ll answer questions about your health and lifestyle. This study is currently active but not recruiting new participants. Your responses can help improve public health efforts in Russia!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Respondents are aged 18 and above.
  • Respondents provide informed consent via telephone at the beginning of the survey.
  • Exclusion Criteria:
  • Respondents refuse to provide informed consent.
  • Respondents are severely ill or too frail to participate.
  • Respondents have cognitive problems.
  • Respondents have hearing or speaking problems.

About I.M. Sechenov First Moscow State Medical University

i.m. Sechenov First Moscow State Medical University is a prestigious institution dedicated to advancing medical education, research, and clinical practice. As a leading center for medical innovation in Russia, the university fosters a collaborative environment for scientific inquiry and the development of novel therapies. With a commitment to high-quality clinical trials, i.m. Sechenov aims to contribute significantly to the global biomedical landscape by evaluating new treatments and improving patient care through rigorous research methodologies and ethical standards.

Locations

Moscow, , Russian Federation

Patients applied

0 patients applied

Trial Officials

Ekaterina Aleksandrova

Principal Investigator

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported